Vesalius Biocapital Partners - aVenture Asset Manager Research
Location
Strassen, Luxembourg Canton, LU
Founded
2007
Vesalius Biocapital Partners is a European venture capital firm focused on life sciences investments. With over €120 million under management across multiple funds, they primarily invest in companies developing therapeutics, medical devices, diagnostics, and digital health solutions. The firm typically acts as a lead investor, targeting early to growth-stage opportunities in Europe.
Notable portfolio companies include Caresyntax, a surgical intelligence platform, Dearhealth, a chronic care management solution, and Sword Health, a digital musculoskeletal therapy provider. Vesalius Biocapital Partners offers extensive industry expertise and a strong network to support their portfolio companies' growth and development in the healthcare sector.
Vesalius Biocapital Partners - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages